Implantation of cardiac defibrillators for primary prevention: A pendulum too far?

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 8, 2008, Pages 1047-1050

  Ferreira, Scott W ^a   Hauptman, Paul J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; VASOACTIVE AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATION; EDITORIAL; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; MORTALITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; SURVIVAL RATE;

CARDIAC PACING, ARTIFICIAL; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MYOCARDIAL ISCHEMIA; PATIENT SELECTION; PRIMARY PREVENTION; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 55249118633     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.8.1047     Document Type: Editorial

References (28)

1. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346, 877-883 (2002).
2. Hamilton N. Monty: Final Years of the Field-Marshal 1944-1976. McGraw-Hill Book Company, NY, USA (1987).
3. Hlatky MA. Underuse of evidence-based therapies. Circulation 110(6), 644-645 (2004).
4. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J. Am. Coll. Cardiol. 41(1), 56-61 (2003).
5. Smith NL, Chan JD, Rea TD et al. Time trends in the use of β-blockers and other pharmacotherapies in older adults with congestive heart failure. Am. Heart J. 148(4), 710-717 (2004).
6. Parsonnet V. Survey of cardiac pacing and implanted defibrillator practice patterns in the United States in 1997. Pacing Clin. Electrophysiol. 24(5), 842-855 (2001).
7. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225-237 (2005).
8. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator for congestive heart failure. N. Engl. J. Med. 350, 2140-2150 (2004).
9. Epstein AE, DiMarco, JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J. Am. Coll. Cardiol. 51, 1-62 (2008).
10. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J. Am. Coll. Cardiol. 48, 247-346 (2006).
11. Maisel WH, Sweeney MO. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA 2186(7), 793-799 (2001).
12. Curtis LH, Al-Khatib SM, Shea AM et al. Sex differences in the use of implantable cardioverter-defibrillacors for primary and secondary prevention of sudden cardiac death. JAMA 298, 1517-1524 (2007).
13. Swindle J, Burroughs TE, Schnitzler MA, Hauptman PJ. Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure. Am. Heart J. 156(2), 322-328 (2008).
14. Goldenberg I, Vyas AK, Hall WJ et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J. Am. Coll. Cardiol. 51, 288-296 (2008).
15. Mark DB, Nelson CL, Anstrom KJ et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the sudden death in heart failure trial (SCD-HeFT). Circulation 114, 135-142 (2006).
16. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N. Engl. J. Med. 353, 1471-1480 (2005).
17. Maisel WH. Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions. JAMA 294, 955-958 (2005).
18. Mehra MR, Greenberg BH. Cardiac resynchronization therapy: caveat medicus. J. Am. Coll. Cardiol. 43, 1145-1148 (2004).
19. Lindenfeld J, Feldman AM, Saxon L et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 115, 204-212 (2007).
20. Ector H, Vardas P. Current use of pacemakers, implantable cardioverter- defibrillators and resynchronization devices: data from the registry of the European Heart Rhythm Association. Eur. Heart J. (Suppl. 9), 144-149 (2007).
21. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch. Int. Med. 162(15), 1682-1688 (2002).
22. Fonarow GC, Abraham WT, Albert NM et al. Prospective evaluation of β-blocker use at the time of hospital failure performance measure: results from OPTIMIZE-HF. J. Card. Fail. 13(9), 722-731 (2007).
23. Stevenson LW, Desai AS. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. J. Card. Fail. 12, 407-412 (2006).
24. Goldstein NE, Lampert R, Bradley E et al. Management of implantable cardioverter defibrillators in end-of-life care. Ann. Intern. Med. 141, 835-838 (2004).
25. Hauptman PJ, Swindle J, Hussain Z, Burroughs TE. Physician attitudes toward end-stage heart failure: results of a national survey. Am. J. Med. 121, 127-135 (2008).
26. Buxton AE, Lee KL, Fisher JD et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. multicenter unsustained tachycardia trial investigators. N. Engl. J. Med. 341, 1882-1890 (1999).
27. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N. Engl. J. Med. 335, 1993-1940 (1996).
28. Kadish A, Dyer A, Daubert JP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N. Engl. J. Med. 350, 2151-2158 (2004).